First Horizon Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25
| Closed | -$339 | – | 2369 |
|
|
2025
Q1 | $339 | Hold |
25
| – | – | ﹤0.01% | 2257 |
|
|
2024
Q4 | $509 | Hold |
25
| – | – | ﹤0.01% | 2188 |
|
|
2024
Q3 | $728 | Hold |
25
| – | – | ﹤0.01% | 2183 |
|
|
2024
Q2 | $580 | Hold |
25
| – | – | ﹤0.01% | 2187 |
|
|
2024
Q1 | $513 | Sell |
25
-195
| -89% | -$4K | ﹤0.01% | 2217 |
|
|
2023
Q4 | $4.72K | Hold |
220
| – | – | ﹤0.01% | 1815 |
|
|
2023
Q3 | $4.54K | Sell |
220
-11
| -5% | -$227 | ﹤0.01% | 1776 |
|
|
2023
Q2 | $6.82K | Hold |
231
| – | – | ﹤0.01% | 1693 |
|
|
2023
Q1 | $5.32K | Buy |
231
+16
| +7% | +$369 | ﹤0.01% | 1794 |
|
|
2022
Q4 | $5.98K | Hold |
215
| – | – | ﹤0.01% | 1755 |
|
|
2022
Q3 | $6K | Hold |
215
| – | – | ﹤0.01% | 1691 |
|
|
2022
Q2 | $6K | Buy |
215
+200
| +1,333% | +$5.58K | ﹤0.01% | 1756 |
|
|
2022
Q1 | $0 | Sell |
15
-200
| -93% | – | ﹤0.01% | 1850 |
|
|
2021
Q4 | $9K | Hold |
215
| – | – | ﹤0.01% | 1548 |
|
|
2021
Q3 | $10K | Buy |
+215
| New | +$10K | ﹤0.01% | 1526 |
|